Paul uses his scientific background in bacteriology, virology, and genetics to counsel clients on a wide range of intellectual property issues while considering each client’s specific business objectives. He focuses on patent preparation and prosecution for foreign and domestic clients across technologies that include medical devices , biotechnology, and telecommunications. Paul counsels on patent validity, patent infringement, patentability of inventions, and freedom to operate. He also has extensive experience handling US Patent Law in contract litigation involving the sale of intellectual property.
Paul additionally represents clients ranging from small private companies to large Fortune 500 corporations in complex patent-litigation matters. He has counseled clients in abbreviated new drug application (ANDA) patent litigation, including a multinational corporation pertaining to a blockbuster over-the-counter medication.